Manuela Roncella

Manuela Roncella

Auto-generated profile, based on publicly available information

Manuela Roncella

Breast Surgery, Breast Centre, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2023 in Therapeutic Advances in Medical Oncology
Verified
Journal Article
Open access
MGMaria Luisa Gasparri
Maria Luisa Gasparri
SASARA PAOLA ALBASINI
SARA PAOLA ALBASINI
MTMarta Truffi
Marta Truffi
KFKarin Favilla
Karin Favilla
BTBarbara Tagliaferri
Barbara Tagliaferri
FCFabio Corsi
Fabio Corsi
Background: Systemic inflammatory markers draw great interest as potential blood-based prognostic factors in several oncological settings. Objectives: The aim of this study is to evaluate whether neutrophil-to-lymphocyte ratio (NLR) and pan-immune-inflammation value (PIV) predict nodal pathologic complete response (pCR) after neoadjuvant chemotherapy (NAC) in node-positive (cN+) breast cancer (BC) patients. Design: Clinically, cN+ BC patients undergoing NAC followed by breast and axillary surgery were enrolled in a multicentric study from 11 Breast Units. Methods: Pretreatment blood counts were collected for the analysis and used to calculate NLR and PIV. Logistic regression analyses were performed to evaluate independent predictors of nodal pCR. Results: A total of 1274 cN+ BC patients were included. Nodal pCR was achieved in 586 (46%) patients. At multivariate analysis, low NLR [odds ratio (OR) = 0.71; 95% CI, 0.51–0.98; p = 0.04] and low PIV (OR = 0.63; 95% CI, 0.44–0.90; p = 0.01) were independently predictive of increased likelihood of nodal pCR. A sub-analysis on cN1 patients ( n = 1075) confirmed the statistical significance of these variables. PIV was significantly associated with axillary pCR in estrogen receptor (ER)−/human epidermal growth factor receptor 2 (HER2)+ (OR = 0.31; 95% CI, 0.12–0.83; p = 0.02) and ER−/HER2− (OR = 0.41; 95% CI, 0.17–0.97; p = 0.04) BC patients. Conclusion: This study found that low NLR and PIV levels predict axillary pCR in patients with BC undergoing NAC. Registration: Eudract number NCT05798806.

1 December 2017 in Clinical Nuclear Medicine
Verified
Journal Article
Closed access
GMGianpiero Manca
Gianpiero Manca
SMSara Mazzarri
Sara Mazzarri
DRDomenico Rubello
Domenico Rubello
ETElisa Tardelli
Elisa Tardelli
RBRoberto Delgado Bolton
Roberto Delgado Bolton
PCPatrick M. Colletti
Patrick M. Colletti
Purpose: Regarding radioguided surgery, the concept of “radioguided occult lesion localization” (ROLL) is based on both preoperative interventional imaging and intraoperative radioguided detection of a clinically occult neoplastic lesion.Methods: This methodology consists in the direct administration into the lesion of99mTc–macroaggregated human albumin formed by relatively large particles retained at the injection site, which direct radioguided excisional biopsy.Results: This modality has expanded from the classic application of ROLL for nonpalpable breast lesions to other tumors, such as solitary pulmonary nodules or recurrences from differentiated thyroid carcinoma. In 2011, in order to improve the classification of different radioguided surgical procedures, ROLL applications were included in the more complete concept of GOSTT (Guided intraOperative Scintigraphic Tumor Targeting). This concept was introduced to include the entire range of basic and advanced radioguided procedures necessary to supply a “road map” for the surgeon.Conclusions: The terms ROLL and GOSTT have further developed by incorporating novel modalities such as hybrid tracers for simultaneous fluorescence and radioactive signal detection and innovative navigation systems based on mixed-reality protocols.

26 June 2023 in Breast Cancer
Verified
Journal Article
Open access
PDF file
MGmatteo ghilli
matteo ghilli
MMMaria Donatella Mariniello
Maria Donatella Mariniello
FFFrancesca Ferré
Francesca Ferré
RMRiccardo Morganti
Riccardo Morganti
EPEnrico Perre
Enrico Perre
MRM. Roncella
M. Roncella
Introduction: The oncoplastic conservative surgery was developed as a natural evolution of traditional surgery, attempting to improve the therapeutic and aesthetic outcomes where tumor resection could be followed by not-adequate results. Our primary aim is to evaluate how patient satisfaction and quality-of-life after conservative oncoplastic surgery, using BREAST-Q (BCT Module), change pre- and post-operatively. The secondary aim is to compare patient-reported outcome after oncoplastic or traditional conservative surgery. Patients and methods: We enrolled 647 patients who underwent traditional conservative surgery or oncoplastic surgery from January 2020 to December 2022. Only 232 women (35.9%) completed the BREAST-Q questionnaire on a web-based platform, at the preoperative phase and 3 months after treatment. Results: The average score of “Psychosocial well-being” and “Satisfaction with Breasts” 3 months after surgery showed a statistically significant improvement, while the average score for “Physical well-being: Chest” at 3 months showed a worsening compared to the baseline. “Sexual well-being” did not show statistically significant change. A significant difference between the post-operative outcome of oncoplastic surgery and traditional surgery was observed only for Physical well-being (better for traditional surgery). Conclusions: The study showed significant improvement in patient-reported outcomes 3 months after the surgery, except for physical discomfort that increases especially after oncoplastic surgery. Furthermore, our data, as well as many others, point to the appropriateness of using OCS where there is an effective indication, while the perspective of patients cannot find significant superiority over TCS in any of the areas analyzed.

2 October 2021 in The Breast
Verified
Journal Article
Open access
FCFabio Corsi
Fabio Corsi
SASara Albasini
Sara Albasini
LSLuca Sorrentino
Luca Sorrentino
GAGiulia Armatura
Giulia Armatura
CCClaudia Carolla
Claudia Carolla
SFSecondo Folli
Secondo Folli
Type of axillary surgery in breast cancer (BC) patients who convert from cN + to ycN0 after neoadjuvant chemotherapy (NAC) is still debated. The aim of the present study was to develop and validate a preoperative predictive nomogram to select those patients with a low risk of residual axillary disease after NAC, in whom axillary surgery could be minimized. 1950 clinically node-positive BC patients from 11 Breast Units, treated by NAC and subsequent surgery, were included from 2005 to 2020. Patients were divided in two groups: those who achieved nodal pCR vs. those with residual nodal disease after NAC. The cohort was divided into training and validation set with a geographic separation criterion. The outcome was to identify independent predictors of axillary pathologic complete response (pCR). Independent predictive factors associated to nodal pCR were axillary clinical complete response (cCR) after NAC (OR 3.11, p < 0.0001), ER-/HER2+ (OR 3.26, p < 0.0001) or ER+/HER2+ (OR 2.26, p = 0.0002) or ER-/HER2- (OR 1.89, p = 0.009) BC, breast cCR (OR 2.48, p < 0.0001), Ki67 > 14% (OR 0.52, p = 0.0005), and tumor grading G2 (OR 0.35, p = 0.002) or G3 (OR 0.29, p = 0.0003). The nomogram showed a sensitivity of 71% and a specificity of 73% (AUC 0.77, 95%CI 0.75–0.80). After external validation the accuracy of the nomogram was confirmed. The accuracy makes this freely-available, nomogram-based online tool useful to predict nodal pCR after NAC, translating the concept of tailored axillary surgery also in this setting of patients.

1 February 2017 in Clinical Breast Cancer
Verified
Journal Article
Closed access
MGmatteo ghilli
matteo ghilli
MMMaria Donatella Mariniello
Maria Donatella Mariniello
GFGiovanni Fanelli
Giovanni Fanelli
FCFrancesca Cascione
Francesca Cascione
AFAndrea Fontana
Andrea Fontana
MRManuela Roncella
Manuela Roncella

1 October 2020 in European Journal of Surgical Oncology
Verified
Journal Article
Closed access
MSMargherita Serra
Margherita Serra
ALA. Quattrini Li
A. Quattrini Li
LCL. Cataliotti
L. Cataliotti
ECE. Cianchetti
E. Cianchetti
FCFabio Corsi
Fabio Corsi
VTV.L. Troilo
V.L. Troilo